FRI0486 Intravenous golimumab in adult patients with active psoriatic arthritis: efficacy and safety through week 24

A Kavanaugh; ME Husni; DD Harrison; L Kim; KH Lo; EC Hsia

doi:10.1136/annrheumdis-2017-eular.1165

Article info

PDF

Poster Presentations

Psoriatic arthritis

FRI0486 Intravenous golimumab in adult patients with active psoriatic arthritis: efficacy and safety through week 24

Free

Authors

A Kavanaugh 1University of California, San Diego PubMed articles Google scholar articles
ME Husni 2Cleveland Clinic, Cleveland PubMed articles Google scholar articles
DD Harrison 3Janssen Research & Development, LLC, Spring House PubMed articles Google scholar articles
L Kim 3Janssen Research & Development, LLC, Spring House PubMed articles Google scholar articles
KH Lo 3Janssen Research & Development, LLC, Spring House PubMed articles Google scholar articles
EC Hsia 4Janssen Research & Development, LLC/University of Pennsylvania School of Medicine, Spring House/Philadelphia, United States PubMed articles Google scholar articles

Citation

Kavanaugh A, Husni M, Harrison D, et al

FRI0486 Intravenous golimumab in adult patients with active psoriatic arthritis: efficacy and safety through week 24

Annals of the Rheumatic Diseases 2017;76:671-672.

Publication history

First published June 15, 2017.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password